Recorded April 22, 2021 | On-Demand Webinar
Review the scope of FDA authority of drug promotion and advertising. Define “label” and “labeling” and “false and “misleading”. Gain insight on FDA’s social media guidance, use of off-label information, and considerations for other government and state entities. Review the role of a corporate compliance program in managing the risks of marketing a drug.
This session was recorded as part of FDLI’s virtual Introduction to Drug Law and Regulation course in April 2021.